Assessment of clinical and biological effect of single fraction versus fractionated palliative radiotherapy of bone metastases

Value of bone resorption markers to predict skeletal related events and response to bisphosphonate therapy in patients with bone metastases

Pattern of relapse and treatment outcome of bladder cancer patient retrospective analysis : 2005-2011 single institution experience

Localized cancer bladder: Predictive value of the G1-check points for response to adjuvant therapy

Effect of protracted radiotherapy treatment on outcome of head and neck cancer patients : NEMROCK Experience

Study of the delayed effect of hypofractionated external beam radiotherapy with concurrent boost in the treatment of localized prostate cancer

Biochemical markers of bone metabolism in breast cancer patients with bone metastases

Treatment and prognosis of breast cancer with bone metastases only as first sign of distant relapse

Gemcitabine as monotherapy for locally advanced and/or metastatic carcinoma of bilharzial bladder in comparison with epirubicin

Biochemical markers of bone metabolism in breast cancer patients with bone metastases